Table II.
Characteristic | Patients, n (%) |
---|---|
Median age (range), years | 63.5 (47–76) |
Sex ratio, male/female | 22/20 |
TNM stage at diagnosis, n (%) | |
4 | 40 (95.2) |
3 | 0 (0.0) |
2 | 2 (4.8) |
Metastatic sites at diagnosis, n (%) | |
0 | 2 (4.8) |
1 | 28 (66.6) |
2 | 11 (26.2) |
3 | 1 (2.4) |
TNM stage at the start of second-line gemcitabine, n (%) | |
4 | 41 (97.6) |
3 | 0 (0.0) |
2 | 1 (2.4) |
TNM, tumor-node-metastasis.